Go to Contents Go to Navigation

EU says to purchase up to 300 mln doses of BioNTech/Pfizer v

WORLD 2020/11/26 13:55
Special:

The European Union (EU) will authorize a contract for the purchase of up to 300 million doses of the COVID-19 vaccine jointly developed by German company BioNTech and its American partner Pfizer, European Commission President Ursula von der Leyen said on Tuesday.

"This is the most promising vaccine so far," she said on Twitter. The contract, due to be reached on Wednesday, will be the fourth one the EU secures with a pharmaceutical company to buy vaccines for COVID-19.

The BioNTech/Pfizer vaccine candidate has proved to be more than 90 percent effective in preventing COVID-19 infection in participants with no proven previous SARS-CoV-2 infection, the two companies announced on Monday.

As the world is struggling to contain the COVID-19 pandemic, countries including Germany, China, Russia, the United Kingdom and the United States are racing to find a vaccine.

According to the website of the World Health Organization, as of Nov. 3, there were 202 COVID-19 candidate vaccines being developed worldwide, and 47 of them were in clinical trials.

Keywords
Latest News Culture
  • 1

    Dragon Song Tavern Launches Free Major Summ

  • 2

    Gravitycoin: Redefining DeFi with AI and Sm

  • 3

    Dominica’s Citizenship by Investment Prog

  • 4

    Dominica’s Citizenship by Investment Prog

  • 5

    EBC Financial Group torna-se Parceiro Ofici

News Focus Culture
  • 1

    China-Japan 'fast track' adds g

  • 2

    五千载古韵向新而行,良

  • 3

    Coastal Delights: Savoring the

  • 4

    Xi Elected to NPC by Inner Mong

  • 5

    MAX MIWU Disposable MINI MIWU S

HOME TOP